Bolt Biotherapeutics (FRA:6LP) YoY EBITDA Growth : 9.66% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Bolt Biotherapeutics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Bolt Biotherapeutics's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 9.66%.

Bolt Biotherapeutics's EBITDA per Share for the three months ended in Mar. 2024 was €-0.40.

Bolt Biotherapeutics YoY EBITDA Growth Historical Data

The historical data trend for Bolt Biotherapeutics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bolt Biotherapeutics YoY EBITDA Growth Chart

Bolt Biotherapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-86.47

36.38

-94.74

8.27

19.51

Bolt Biotherapeutics Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															22.61	17.57	25.89	9.86	9.66

Bolt Biotherapeutics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Bolt Biotherapeutics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-1.803	-	-2.24)	/	\| -2.24 \|
=	19.51 %

Bolt Biotherapeutics's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.402	-	-0.445)	/	\| -0.445 \|
=	9.66 %

Bolt Biotherapeutics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Bolt Biotherapeutics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Bolt Biotherapeutics (FRA:6LP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bolt Biotherapeutics Inc (FRA:6LP) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

BOLT:USA 6LP:Germany

Address

900 Chesapeake Drive, Redwood, CA, USA, 94063

Website

https://www.boltbio.com

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

Bolt Biotherapeutics (FRA:6LP) Headlines

No Headlines